255 related articles for article (PubMed ID: 16114023)
1. Tau-predominant-associated pathology in a sporadic late-onset Hallervorden-Spatz syndrome.
Zarranz JJ; Gómez-Esteban JC; Atarés B; Lezcano E; Forcadas M
Mov Disord; 2006 Jan; 21(1):107-11. PubMed ID: 16114023
[TBL] [Abstract][Full Text] [Related]
2. Neuropathological spectrum of synucleinopathies.
Jellinger KA
Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of TDP-43 and tau pathology in neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome).
Haraguchi T; Terada S; Ishizu H; Yokota O; Yoshida H; Takeda N; Kishimoto Y; Katayama N; Takata H; Akagi M; Kuroda S; Ihara Y; Uchitomi Y
Neuropathology; 2011 Oct; 31(5):531-9. PubMed ID: 21276079
[TBL] [Abstract][Full Text] [Related]
4. [Hallervorden-Spatz disease with Lewy bodies].
Antoine JC; Tommasi M; Chalumeau A; Jouvet-Telinge A; Bourrat C
Rev Neurol (Paris); 1985; 141(12):806-9. PubMed ID: 3008295
[TBL] [Abstract][Full Text] [Related]
5. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration.
Thomas M; Hayflick SJ; Jankovic J
Mov Disord; 2004 Jan; 19(1):36-42. PubMed ID: 14743358
[TBL] [Abstract][Full Text] [Related]
6. Adult onset Hallervorden-Spatz syndrome or Seitelberger's disease with late onset: variants of the same entity? A clinico-pathological study.
Gaytan-Garcia S; Kaufmann JC; Young GB
Clin Neuropathol; 1990; 9(3):136-42. PubMed ID: 2364593
[TBL] [Abstract][Full Text] [Related]
7. Widespread expression of alpha-synuclein and tau immunoreactivity in Hallervorden-Spatz syndrome with protracted clinical course.
Saito Y; Kawai M; Inoue K; Sasaki R; Arai H; Nanba E; Kuzuhara S; Ihara Y; Kanazawa I; Murayama S
J Neurol Sci; 2000 Aug; 177(1):48-59. PubMed ID: 10967182
[TBL] [Abstract][Full Text] [Related]
8. Alpha-synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies.
Neumann M; Adler S; Schlüter O; Kremmer E; Benecke R; Kretzschmar HA
Acta Neuropathol; 2000 Nov; 100(5):568-74. PubMed ID: 11045680
[TBL] [Abstract][Full Text] [Related]
9. [Neuropathology of tauopathies and synucleinopathies, and neuroanatomy of sleep disorders: meeting the challenge].
Hauw JJ; Hausser-Hauw C; Duyckaerts C
Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S59-70. PubMed ID: 14646802
[TBL] [Abstract][Full Text] [Related]
10. An atypical autopsy case of Lewy body disease with clinically diagnosed major depression: a clinical, radiological and pathological study.
Iritani S; Tsuchiya K; Arai T; Akiyama H; Ikeda K
Neuropathology; 2008 Dec; 28(6):652-9. PubMed ID: 18410279
[TBL] [Abstract][Full Text] [Related]
11. Juvenile-onset generalized neuroaxonal dystrophy (Hallervorden-Spatz disease) with diffuse neurofibrillary and lewy body pathology.
Wakabayashi K; Fukushima T; Koide R; Horikawa Y; Hasegawa M; Watanabe Y; Noda T; Eguchi I; Morita T; Yoshimoto M; Iwatsubo T; Takahashi H
Acta Neuropathol; 2000 Mar; 99(3):331-6. PubMed ID: 10663979
[TBL] [Abstract][Full Text] [Related]
12. Sporadic late-onset Hallervorden-Spatz disease presenting as parkinsonism in a Chinese patient.
Wang LN; Huang KW; Liu ZY
Chin Med J (Engl); 1990 Aug; 103(8):686-8. PubMed ID: 2122948
[TBL] [Abstract][Full Text] [Related]
13. Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions.
Popescu A; Lippa CF; Lee VM; Trojanowski JQ
Arch Neurol; 2004 Dec; 61(12):1915-9. PubMed ID: 15596612
[TBL] [Abstract][Full Text] [Related]
14. An autopsied case of juvenile parkinsonism and dementia, with a widespread occurrence of Lewy bodies and spheroids.
Odawara T; Iseki E; Yagishita S; Amano N; Kosaka K; Hasegawa K; Matsuda Y; Kowa H
Clin Neuropathol; 1992; 11(3):131-4. PubMed ID: 1319291
[TBL] [Abstract][Full Text] [Related]
15. [A case of Hallervorden-Spatz syndrome with marked atrophy of the brainstem and cerebellum].
Sodeyama N; Arai M; Sanjoh N; Orimo S; Tamaki M
Rinsho Shinkeigaku; 1993 May; 33(5):525-9. PubMed ID: 8365059
[TBL] [Abstract][Full Text] [Related]
16. Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and alpha-synuclein pathology.
Newman J; Rissman RA; Sarsoza F; Kim RC; Dick M; Bennett DA; Cotman CW; Rohn TT; Head E
Acta Neuropathol; 2005 Aug; 110(2):135-44. PubMed ID: 15986225
[TBL] [Abstract][Full Text] [Related]
17. Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein.
Arawaka S; Saito Y; Murayama S; Mori H
Neurology; 1998 Sep; 51(3):887-9. PubMed ID: 9748051
[TBL] [Abstract][Full Text] [Related]
18. Lewy bodies in progressive supranuclear palsy represent an independent disease process.
Uchikado H; DelleDonne A; Ahmed Z; Dickson DW
J Neuropathol Exp Neurol; 2006 Apr; 65(4):387-95. PubMed ID: 16691119
[TBL] [Abstract][Full Text] [Related]
19. Adult Hallervorden-Spatz syndrome simulating amyotrophic lateral sclerosis.
Vasconcelos OM; Harter DH; Duffy C; McDonough B; Seidman JG; Seidman CE; Campbell WW
Muscle Nerve; 2003 Jul; 28(1):118-22. PubMed ID: 12811783
[TBL] [Abstract][Full Text] [Related]
20. Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology.
Galvin JE; Giasson B; Hurtig HI; Lee VM; Trojanowski JQ
Am J Pathol; 2000 Aug; 157(2):361-8. PubMed ID: 10934140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
